Literature DB >> 15290858

Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope.

Karen K Jette1, Devalina Law, Eric A Schmitt, Glen S Kwon.   

Abstract

PURPOSE: The aim of this work was to study the assembly, drug loading, and stability of poly(ethylene glycol)-block-poly(epsilon-caprolactone) (PEG-b-PCL) micelles.
METHODS: Three PEG-b-PCL compositions with PCL number average molecular weights of 1000, 2500, and 4000 g/mol were used. The assembly of PEG-b-PCL micelles, induced by the addition of water to acetonitrile (ACN), was characterized with 1H nuclear magnetic resonance spectroscopy (1H-NMR) and dynamic light scattering (DLS) with and without the presence of fenofibrate, a poorly water-soluble drug. PEG-b-PCL micelles with encapsulated fenofibrate were prepared through the removal of a negative ACN-water azeotrope under reduced pressure. Fenofibrate content was measured using reverse-phase high-performance liquid chromatography (HPLC), whereas the kinetic stability of PEG-b-PCL micelles with and without encapsulated fenofibrate was evaluated using size exclusion chromatography (SEC).
RESULTS: The critical water content (CWC), the water content at which amphiphilic block copolymer (ABC) micelle assembly begins, was determined using DLS and ranged from 10% to 30% water, depending on both PCL molecular weight and PEG-b-PCL concentration. As the water content was increased, the PEG-b-PCL unimers assembled into swollen structures with hydrodynamic diameters ranging from 200 to 800 nm. The 1H-NMR peaks associated with the PCL block exhibited line-broadening, following the addition of D2O, indicating that the PCL blocks reside in the core of the PEG-b-PCL micelle. With further addition of water, the PCL cores collapsed to form fairly monodisperse PEG-b-PCL micelles (20-60 nm). In the presence of fenofibrate, the CWC value was lowered, perhaps due to hydrophobic interactions of fenofibrate and the PCL block. Further addition of water and subsequent evaporation of the negative ACN-water azeotrope resulted in fenofibrate-loaded PEG-b-PCL micelles of under 50 nm. The extent of fenofibrate encapsulation was dependent on PCL block size. At a polymer concentration of 1.0 mg/ml, PEG-b-PCL (5000:4000) and (5000:2500) micelles could encapsulate more than 90% of the initial loading level of fenofibrate, whereas PEG-b-PCL (5000:1000) micelles encapsulate only 28%. SEC experiments revealed that PEG-b-PCL (5000:4000) and (5000:2500) micelles eluted intact, indicating kinetic stability, whereas PEG-b-PCL (5000:1000) micelles eluted primarily as unimers.
CONCLUSIONS: PEG-b-PCL in ACN assembles with fenofibrate into drug-loaded polymeric micelles with the addition of water and the subsequent removal of a negative ACN-water azeotrope.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290858     DOI: 10.1023/b:pham.0000033005.25698.9c

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

Review 1.  Soluble self-assembled block copolymers for drug delivery.

Authors:  G S Kwon; T Okano
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

2.  Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel.

Authors:  X Zhang; H M Burt; G Mangold; D Dexter; D Von Hoff; L Mayer; W L Hunter
Journal:  Anticancer Drugs       Date:  1997-08       Impact factor: 2.248

3.  Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice.

Authors:  So Yeon Kim; Young Moo Lee; Doo J Baik; Ju S Kang
Journal:  Biomaterials       Date:  2003-01       Impact factor: 12.479

4.  Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B.

Authors:  A Lavasanifar; J Samuel; G S Kwon
Journal:  J Control Release       Date:  2001-11-09       Impact factor: 9.776

Review 5.  Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Authors:  J A Balfour; D McTavish; R C Heel
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

6.  Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818.

Authors:  C Allen; Y Yu; D Maysinger; A Eisenberg
Journal:  Bioconjug Chem       Date:  1998 Sep-Oct       Impact factor: 4.774

7.  The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives.

Authors:  A Lavasanifar; J Samuel; G S. Kwon
Journal:  Colloids Surf B Biointerfaces       Date:  2001-10       Impact factor: 5.268

8.  Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone.

Authors:  C Allen; J Han; Y Yu; D Maysinger; A Eisenberg
Journal:  J Control Release       Date:  2000-02-03       Impact factor: 9.776

9.  Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer.

Authors:  H S Yoo; T G Park
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

Review 10.  Amphiphilic block copolymers for drug delivery.

Authors:  Monica L Adams; Afsaneh Lavasanifar; Glen S Kwon
Journal:  J Pharm Sci       Date:  2003-07       Impact factor: 3.534

View more
  16 in total

Review 1.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

Review 2.  Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery.

Authors:  Hamidreza Montazeri Aliabadi; Mostafa Shahin; Dion R Brocks; Afsaneh Lavasanifar
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

3.  Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles.

Authors:  MaLing Gou; XiuLing Zheng; Ke Men; Juan Zhang; BiLan Wang; Lei Lv; XiuHong Wang; YinLan Zhao; Feng Luo; LiJuan Chen; Xia Zhao; YuQuan Wei; ZhiYong Qian
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

4.  Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors:  Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Recent Pat Nanomed       Date:  2012

5.  Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells.

Authors:  Yunqi Zhao; Shaofeng Duan; Xing Zeng; Chunjing Liu; Neal M Davies; Benyi Li; M Laird Forrest
Journal:  Mol Pharm       Date:  2012-05-01       Impact factor: 4.939

6.  Interrogating the relationship between the microstructure of amphiphilic poly(ethylene glycol-b-caprolactone) copolymers and their colloidal assemblies using non-interfering techniques.

Authors:  Khandokar Sadique Faisal; Andrew J Clulow; Marta Krasowska; Todd Gillam; Stanley J Miklavcic; Nathan H Williamson; Anton Blencowe
Journal:  J Colloid Interface Sci       Date:  2021-08-17       Impact factor: 8.128

7.  Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats.

Authors:  May P Xiong; Jaime A Yáñez; Connie M Remsberg; Yusuke Ohgami; Glen S Kwon; Neal M Davies; M Laird Forrest
Journal:  J Control Release       Date:  2008-03-25       Impact factor: 9.776

8.  A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel.

Authors:  Kang Moo Huh; Hyun Su Min; Sang Cheon Lee; Hong Jae Lee; Sungwon Kim; Kinam Park
Journal:  J Control Release       Date:  2007-11-22       Impact factor: 9.776

9.  Porous carriers for controlled/modulated drug delivery.

Authors:  G Ahuja; K Pathak
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

10.  Drug loading of polymeric micelles.

Authors:  Tobias Miller; Gwenaelle van Colen; Bjoern Sander; Mariola Monika Golas; Senta Uezguen; Markus Weigandt; Achim Goepferich
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.